NCT07409844 2026-02-20
RESET C2
Zealand University Hospital
Phase 2 Not yet recruiting
Clinical Trials
15 trialsNCT07224022 2026-02-04
NACho
Duke University
Phase 2 Not yet recruiting
NCT07178717 2025-09-17
REFISH
Vall d'Hebron Institute of Oncology
Phase 2 Not yet recruiting
NCT07156682 2025-09-05
QL1706 Plus XELOX as Neoadjuvant Therapy for MSS/pMMR Clinical Stage III Colon Cancer
Qilu Hospital of Shandong University
Phase 2 Not yet recruiting
NCT06646445 2025-06-13
PREMICES
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2 Not yet recruiting
NCT06999252 2025-05-31
Rimegepant Combined With PD-1 in Liver Metastasis Colorectal Cancer Patients
Fudan University
Phase 2 Not yet recruiting
NCT06890624 2025-03-27
OPTICAL-3
Sun Yat-sen University
Phase 2 Not yet recruiting
NCT06790212 2025-03-17
Neoadjuvant CAPOX Plus Ivonescimab Versus CAPOX for Locally Advanced Colon Cancer
Sun Yat-sen University
Phase 2 Not yet recruiting
NCT06665087 2024-10-30
CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC
Fudan University
Phase 2 Not yet recruiting
NCT06652412 2024-10-28
CGA Guided Ultrafractionated RT and Systemic Treatment in Elderly or Frail Patients with Inoperable Localized CRC
Fudan University
Phase 2 Not yet recruiting
NCT06491355 2024-07-09
First-Line Treatment Induced With mFOLFOX6 and HLX04 Regimen, Following Combined With Serplulimab in MSS Initially Unresectable Metastatic Colorectal Cancer
Sir Run Run Shaw Hospital
Phase 2 Not yet recruiting
NCT06255379 2024-04-29
Study of Fruquintinib Combined With Tegafur Gimeracil Oteracil in Patients With Metastatic Colorectal Cancer
Guangzhou University of Traditional Chinese Medicine
Phase 2 Not yet recruiting
NCT06301386 2024-03-08
Everolimus Combined With PD-1 in Advanced Colorectal Cancer Patients
Fudan University
Phase 2 Not yet recruiting
NCT06218888 2024-01-23
A Phase II Clinical Study of the Efficacy and Safety of Tislelizumab Combined With Fruquintinib and Chidamide in the Treatment of Unresectable or Advanced Microsatellite Stabilized (MSS/pMMR) Colorectal Cancer With Liver Metastases
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT05231850 2022-02-09
A Phase II Study of Tislelizumab as Adjuvant Therapy for Patients With Stage â…¡ and Stage â…¢ Colon Cancer and dMMR/MSI.
The First Affiliated Hospital of Zhengzhou University
Phase 2 Not yet recruiting